B. Riley Has Pessimistic Outlook of Abacus Life Q4 Earnings

Key Points

• B. Riley has downgraded its Q4 2025 earnings estimate for Abacus Life to $0.18 per share from $0.20, reflecting a cautious outlook on the company's performance.
• Despite the downgrade, several brokerages maintain a positive stance on Abacus Life, with a current consensus rating of "Buy" and a price target averaging $13.70.
• Abacus Life's stock recently traded at $6.36 and reported revenues of $56.23 million in the latest quarter, exceeding the consensus estimate of $43.38 million.

Abacus Life, Inc. (NASDAQ:ABL - Free Report) - Stock analysts at B. Riley reduced their Q4 2025 EPS estimates for Abacus Life in a research report issued on Wednesday, August 13th. B. Riley analyst R. Binner now anticipates that the company will post earnings of $0.18 per share for the quarter, down from their prior estimate of $0.20. The consensus estimate for Abacus Life's current full-year earnings is $0.62 per share.

Several other brokerages also recently weighed in on ABL. Wall Street Zen upgraded shares of Abacus Life from a "hold" rating to a "buy" rating in a research note on Saturday, August 9th. Maxim Group assumed coverage on shares of Abacus Life in a report on Tuesday, April 29th. They set a "buy" rating and a $14.00 price target for the company. Finally, Piper Sandler cut their price target on shares of Abacus Life from $12.00 to $10.00 and set an "overweight" rating for the company in a report on Wednesday, July 2nd. Six investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Buy" and a consensus price target of $13.70.

Abacus Life Stock Performance

Shares of ABL traded up $0.03 during mid-day trading on Thursday, hitting $6.36. 51,683 shares of the company's stock were exchanged, compared to its average volume of 599,981. Abacus Life has a fifty-two week low of $4.60 and a fifty-two week high of $11.00. The firm has a market capitalization of $615.97 million, a P/E ratio of -106.37 and a beta of 0.01. The business's 50 day moving average is $5.48 and its two-hundred day moving average is $7.01. The company has a current ratio of 0.47, a quick ratio of 0.47 and a debt-to-equity ratio of 0.55.

Abacus Life (NASDAQ:ABL - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The company reported $0.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.16 by $0.06. Abacus Life had a negative net margin of 0.72% and a positive return on equity of 18.19%. The company had revenue of $56.23 million during the quarter, compared to the consensus estimate of $43.38 million.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Millennium Management LLC boosted its position in Abacus Life by 1,629.1% during the fourth quarter. Millennium Management LLC now owns 192,019 shares of the company's stock worth $1,504,000 after acquiring an additional 180,914 shares during the last quarter. Two Sigma Investments LP acquired a new stake in Abacus Life during the fourth quarter worth approximately $617,000. Jane Street Group LLC acquired a new stake in Abacus Life during the fourth quarter worth approximately $282,000. Foundry Partners LLC boosted its position in Abacus Life by 10.5% during the first quarter. Foundry Partners LLC now owns 756,957 shares of the company's stock worth $5,670,000 after acquiring an additional 71,957 shares during the last quarter. Finally, Pacific Ridge Capital Partners LLC acquired a new stake in Abacus Life during the first quarter worth approximately $358,000.

Abacus Life Company Profile

Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.